From COVID-19 to HIV-1, Duke Surgical Sciences blazes the trail in vaccine immunology

By Brooke Walker

The COVID-19 vaccines are one of the greatest discoveries of the past 100 years. Their success has set new standards for how future vaccines should be designed and manufactured: a well-documented safety record, an excellent efficacy rate (up to 95%), and an accelerated production timeline compared with traditional vaccines. The novel mRNA technology that brought about this success was based on decades of research, including seminal work in the Division of Surgical Sciences.

Read more about the researchers and their discoveries at

Duke Surgery News

Share